ViiV Healthcare’s investigational broadly neutralising antibody – N6LS – successfully maintains viral suppression in long-acting treatment of HIV

FHS
March 13, 2025
10:18 am

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced positive findings from the company’s EMBRACE phase IIb study.

Don’t expect RFK Jr. and Dr. Oz to get much done on prevention and wellness

While many critics of Robert F. Kennedy Jr. and Mehmet Oz are focused on their criticisms of vaccines, that focus is somewhat misplaced. The data

November 21, 2024

Beiersdorf announces another share buyback program – Biotech Investments

Beiersdorf Aktiengesellschaft / Key word(s): Share Buyback Beiersdorf Aktiengesellschaft: Beiersdorf announces another share buyback program 26-Feb-2025 / 19:39 CET/CEST Disclosure of an inside information acc.

February 27, 2025

Exclusive: Moderna’s former top scientist has a new startup using AI to improve mRNA therapies

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

January 11, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.